(MENAFN - GlobeNewsWire - Nasdaq) NRx has received a letter from the FDA Office of Generic Drugs indicating preliminary alignment on labeling for NRx's preservative-free ketamine product. ...
(MENAFN - GlobeNewsWire - Nasdaq) NRx has received a letter from the FDA Office of Generic Drugs indicating preliminary alignment on labeling for NRx's preservative-free ketamine product. ...